Who is sponsoring NCT04866355?

NCT04866355 is sponsored by University of Alcala.

What drugs are being tested in NCT04866355?

Interventions in NCT04866355: Lumbar spine manipulation, Hyoscine and Ibuprofen.

What condition does NCT04866355 study?

NCT04866355 studies Women With Primary Dysmenorrhea.

Is NCT04866355 still recruiting?

NCT04866355 is currently completed. Last updated 18 November 2022.

Last reviewed 2022-11-18 · How we verify

NCT04866355

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Lumbar Spine Manipulation Versus Pharmacological Therapy in Young Women With Primary Dysmenorrhea

Completed NA Last updated 18 November 2022

What this trial tests

NA trial testing Lumbar spine manipulation in Women With Primary Dysmenorrhea in 42 participants. Completed in 10 November 2022.

Timeline

28 February 2021

Primary endpoint
20 June 2021

10 November 2022

Quick facts

Lead sponsor	University of Alcala
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	42
Start date	28 February 2021
Primary completion	20 June 2021
Estimated completion	10 November 2022
Sites	2 locations across Spain, Mexico

Drugs / interventions tested

Lumbar spine manipulation
Hyoscine and Ibuprofen — full drug profile →

Conditions studied

Women With Primary Dysmenorrhea — all drugs for Women With Primary Dysmenorrhea →

Sponsor

University of Alcala

Who can join

Adults 18 to 65, female only, with Women With Primary Dysmenorrhea. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Many treatments like acupuncture, manipulative therapy and pharmacological therapy have been proposed to alleviate symptoms associated with dysmenorrhea. However, no study has previously compared lumbar spine manipulation to pharmacological therapy in the treatment of primary dysmenorrhea.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other University of Alcala trials

Trials by the same sponsor.

NCT06599164 — Evaluation of Vastus Medialis Muscle Inhibition in Indoor Soccer Players With and Without ACL Injury · not yet recruiting
NCT06587412 — Treatment of Lateral Epicondylalgia With Shock Waves · NA · recruiting
NCT07333443 — Caffeine and Sport Climbing Performance · NA · completed
NCT07015008 — Sleep and Maximal Fat Oxidation · NA · completed
NCT06723821 — Noninvasive Neuromodulation in the Management of Post-COVID Musculoskeletal Pain · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04866355 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Alcala
Last refreshed: 18 November 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04866355.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing